Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform
| Date | 21st, Jun 2021 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
Recently, researchers discuss their development of cell membrane-based nanoparticles that successfully delivered dexamethasone directly to inflamed lung cells.